Hancock Whitney Corp Regenxbio Inc. Transaction History

Hancock Whitney Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$26.52 - $49.35 $452,484 - $842,009	-17,062 Closed	0 $0
Q3 2020 Nov 05, 2020	SELL	$27.01 - $40.26 $67,254 - $100,247	-2,490 Reduced 12.74%	17,062 $470,000
Q2 2020 Jul 30, 2020	SELL	$27.75 - $43.44 $124,264 - $194,524	-4,478 Reduced 18.64%	19,552 $720,000
Q1 2020 May 08, 2020	BUY	$21.5 - $54.2 $516,645 - $1.3 Million	24,030 New	24,030 $778,000

197

43.2M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $415M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

Stay updated on Hancock Whitney Corp with notifications on news.